Verdonk C A, Rizza R A, Westland R E, Nelson R L, Gerich J E, Service F J
Horm Metab Res. 1980 Apr;12(4):133-5. doi: 10.1055/s-2007-996224.
The Biostator GCIIS was used to clamp circulating glucose at hypoglycemic (42 +/- 1 mg/dl), euglycemic (86 +/- 2 mg/dl), and hyperglycemic (142 +/- 1 mg/dl) levels in normal subjects during a concomitant infusion of insulin (0.1 U/kg/h). Because of limitations in maximal glucose infusion (1 g/min) from the Biostator, a supplementary infusion of glucose was required to accomplish euglycemic and hyperglycemic clamps. The coefficients of variation of blood glucose were 7.06 +/- 1.3%, 5.9 +/- 0.5%, and 6.1 +/- 0.9 for 120 minutes of hypoglycemic, euglycemic, and hyperglycemic clamps, respectively. Despite the occasional interruption of blood flow in the double-lumen catheter and the occasional poor correlation between Biostator and reference glucose method, satisfactory glucose clamps could be maintained for 2 hours.
在正常受试者中,使用生物人工肝支持系统GCIIS在持续输注胰岛素(0.1 U/kg/h)的过程中,将循环葡萄糖水平钳定在低血糖(42±1 mg/dl)、血糖正常(86±2 mg/dl)和高血糖(142±1 mg/dl)水平。由于生物人工肝支持系统的最大葡萄糖输注量有限(1 g/min),因此需要补充输注葡萄糖以完成血糖正常和高血糖钳定。低血糖、血糖正常和高血糖钳定120分钟时,血糖的变异系数分别为7.06±1.3%、5.9±0.5%和6.1±0.9%。尽管双腔导管中偶尔会出现血流中断,且生物人工肝支持系统与参考血糖检测方法之间偶尔存在相关性较差的情况,但仍可维持2小时令人满意的葡萄糖钳定。